SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-16-505167
Filing Date
2016-03-15
Accepted
2016-03-15 16:08:29
Documents
79
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d133632d10k.htm 10-K 929550
2 EX-23.1 d133632dex231.htm EX-23.1 1643
3 EX-31.1 d133632dex311.htm EX-31.1 8396
4 EX-31.2 d133632dex312.htm EX-31.2 8392
5 EX-32.1 d133632dex321.htm EX-32.1 3031
6 EX-32.2 d133632dex322.htm EX-32.2 3016
13 GRAPHIC g133632img001.jpg GRAPHIC 33886
  Complete submission text file 0001193125-16-505167.txt   4539529

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cprx-20151231.xml EX-101.INS 767792
8 XBRL TAXONOMY EXTENSION SCHEMA cprx-20151231.xsd EX-101.SCH 55916
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cprx-20151231_cal.xml EX-101.CAL 61883
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cprx-20151231_def.xml EX-101.DEF 158543
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20151231_lab.xml EX-101.LAB 426450
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20151231_pre.xml EX-101.PRE 308233
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33057 | Film No.: 161506998
SIC: 2834 Pharmaceutical Preparations